Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (23)
A Roberto, MT Greco, L Legramandi, F Galli, M Galli & O Corli. (2017) A comparison between the administration of oral prolonged-release oxycodone-naloxone and transdermal fentanyl in patients with moderate-to-severe cancer pain: a propensity score analysis. Journal of Pain Research 10, pages 2123-2133.
Read now
Read now
Gineke Koopmans-Klein, Joeri Van Op den Bosch, Yvonne van Megen, Hans Prenen, Frank Huygen & Isabelle Mancini. (2017) Prolonged release oxycodone and naloxone treatment counteracts opioid-induced constipation in patients with severe pain compared to previous analgesic treatment. Current Medical Research and Opinion 33:12, pages 2217-2227.
Read now
Read now
Emiliano Petrò, Elena Ruffini, Melania Cappuccio, Valeria Guerini, Gloria Belotti, Sara Fascendini, Cristina Licini & Claudio Marcassa. (2016) Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy–tolerability pilot study. Neuropsychiatric Disease and Treatment 12, pages 559-569.
Read now
Read now
Michael A Ueberall, Alice Eberhardt & Gerhard HH Mueller-Schwefe. (2016) Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice. International Journal of General Medicine 9, pages 39-51.
Read now
Read now
Fabio Guerriero, Anna Roberto, Maria Teresa Greco, Carmelo Sgarlata, Marco Rollone & Oscar Corli. (2016) Long-term efficacy and safety of oxycodone–naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study. Drug Design, Development and Therapy 10, pages 1515-1523.
Read now
Read now
Marzia Lazzari, Claudio Marcassa, Silvia Natoli, Roberta Carpenedo, Clarissa Caldarulo, Maria B Silvi & Mario Dauri. (2016) Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-Step I drugs in elderly patients with chronic pain at high risk of early opioid discontinuation. Clinical Interventions in Aging 11, pages 641-649.
Read now
Read now
Amir Rumman, Zane R. Gallinger & Louis W. C. Liu. (2016) Opioid induced constipation in cancer patients: pathophysiology, diagnosis and treatment. Expert Review of Quality of Life in Cancer Care 1:1, pages 25-35.
Read now
Read now
Michael A Ueberall & Gerhard HH Mueller-Schwefe. (2015) Development of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioids. Journal of Pain Research 8, pages 459-475.
Read now
Read now
Marzia Lazzari, Maria Teresa Greco, Claudio Marcassa, Simona Finocchi, Clarissa Caldarulo & Oscar Corli. (2015) Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis. Drug Design, Development and Therapy 9, pages 5863-5872.
Read now
Read now
Wojciech Leppert. (2015) Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction. Drug Design, Development and Therapy 9, pages 2215-2231.
Read now
Read now
Michael A. Ueberall & Gerhard H. H. Mueller-Schwefe. (2015) Safety and efficacy of oxycodone/naloxone vs. oxycodone vs. morphine for the treatment of chronic low back pain: results of a 12 week prospective, randomized, open-label blinded endpoint streamlined study with prolonged-release preparations. Current Medical Research and Opinion 31:7, pages 1413-1429.
Read now
Read now
Fabio Guerriero, Carmelo Sgarlata, Claudio Marcassa, Giovanni Ricevuti & Marco Rollone. (2015) Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients. Clinical Interventions in Aging 10, pages 1-11.
Read now
Read now
Sabine Hesselbarth, Kai Hermanns & Petra Oepen. (2015) Prolonged-release oxycodone/naloxone in opioid-naïve patients – subgroup analysis of a prospective observational study. Expert Opinion on Pharmacotherapy 16:4, pages 457-464.
Read now
Read now
Thomas Nolte, Ulf Schutter & Oliver Loewenstein. (2014) Cancer pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: results from a non-interventional study. Pragmatic and Observational Research 5, pages 1-13.
Read now
Read now
Gineke Koopmans, Karen Simpson, Javier De Andrés, Eberhard Albert Lux, Michel Wagemans & Yvonne Van Megen. (2014) Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives. Current Medical Research and Opinion 30:11, pages 2389-2396.
Read now
Read now
M. Lazzari, A. F. Sabato, C. Caldarulo, M. Casali, P. Gafforio, C. Marcassa & F. Leonardis. (2014) Effectiveness and tolerability of low-dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain: an observational analysis. Current Medical Research and Opinion 30:4, pages 555-564.
Read now
Read now
Mellar Davis, Harold W Goforth & Pam Gamier. (2013) Oxycodone combined with opioid receptor antagonists: efficacy and safety. Expert Opinion on Drug Safety 12:3, pages 389-402.
Read now
Read now
Sebastiano Mercadante & Antonello Giarratano. (2013) Combined oral prolonged-release oxycodone and naloxone in chronic pain management. Expert Opinion on Investigational Drugs 22:1, pages 161-166.
Read now
Read now
Gill E Mundin, Kevin J Smith, Jana Mysicka, Gerhard Heun, Mathias Krämer, Udo Hahn & Christian Leuner. (2012) Validated in vitro/in vivo correlation of prolonged-release oxycodone/naloxone with differing dissolution rates in relation to gastrointestinal transit times. Expert Opinion on Drug Metabolism & Toxicology 8:12, pages 1495-1503.
Read now
Read now
Philippe Ducrotté & Christian Caussé. (2012) The Bowel Function Index: a new validated scale for assessing opioid-induced constipation. Current Medical Research and Opinion 28:3, pages 457-466.
Read now
Read now
Kai Hermanns, Uwe Junker & Thomas Nolte. (2012) Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain – results from a large observational study. Expert Opinion on Pharmacotherapy 13:3, pages 299-311.
Read now
Read now
William Dunlop, Reiner Uhl, Iftekhar Khan, Anna Taylor & Garry Barton. (2012) Quality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate-to-severe non-malignant pain and opioid-induced constipation: a UK cost-utility analysis. Journal of Medical Economics 15:3, pages 564-575.
Read now
Read now
Benoît Coffin & Christian Caussé. (2011) Constipation assessment scales in adults: a literature review including the new Bowel Function Index. Expert Review of Gastroenterology & Hepatology 5:5, pages 601-613.
Read now
Read now
Articles from other publishers (32)
V. Andresen, G. Becker, T. Frieling, M. Goebel-Stengel, F. Gundling, A. Herold, M. Karaus, J. Keller, M. Kim, P. Klose, H. Krammer, M. E. Kreis, R. Kuhlbusch-Zicklam, J. Langhorst, P. Layer, R. Lenzen-Großimlinghaus, A. Madisch, H. Mönnikes, S. Müller-Lissner, D. Rubin, M. Schemann, J. Schwille-Kiuntke, A. Stengel, M. Storr, I. van der Voort, W. Voderholzer, T. Wedel, S. Wirz, H. Witzigmann & C. Pehl. (2022) Aktualisierte S2k-Leitlinie chronische Obstipation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie & Motilität (DGNM) – April 2022 – AWMF-Registriernummer: 021–019. Zeitschrift für Gastroenterologie 60:10, pages 1528-1572.
Crossref
Crossref
Grace J. Lee, Shin Ae Kim, Yea Jin Kim & Seog Bae Oh. (2021) Naloxone-induced analgesia mediated by central kappa opioid system in chronic inflammatory pain. Brain Research 1762, pages 147445.
Crossref
Crossref
Toshiki Mimura. 2021. Pelvic Floor Disorders. Pelvic Floor Disorders
741
752
.
Bart J. Morlion, Stefan A. Mueller‐Lissner, Renato Vellucci, Wojciech Leppert, Benoît C. Coffin, Sara L. Dickerson & Tony O'Brien. (2017) Oral Prolonged‐Release Oxycodone/Naloxone for Managing Pain and Opioid‐Induced Constipation: A Review of the Evidence. Pain Practice 18:5, pages 647-665.
Crossref
Crossref
. 2018. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
447
696
.
Gertrud Haeseler, Dirk Schaefers, Natalie Prison, Jörg Ahrens, Xiaofei Liu & Annika Karch. (2017) Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone. BMC Anesthesiology 17:1.
Crossref
Crossref
Esther S. Kim. (2017) Oxycodone/Naloxone Prolonged Release: A Review in Severe Chronic Pain. Clinical Drug Investigation 37:12, pages 1191-1201.
Crossref
Crossref
Jeannine Brant, Lisa Keller, Karen McLeod, Chao Hsing Yeh & Linda Eaton. (2017) Chronic and Refractory Pain: A Systematic Review of Pharmacologic Management in Oncology
. Clinical Journal of Oncology Nursing 21:3, pages 31-59.
Crossref
Crossref
Zengdong Meng, Jing Yu, Michael Acuff, Chong Luo, Sanrong Wang, Lehua Yu & Rongzhong Huang. (2017) Tolerability of Opioid Analgesia for Chronic Pain: A Network Meta-Analysis. Scientific Reports 7:1.
Crossref
Crossref
Magdalena Kocot-KępskaRenata ZajączkowskaAnna Przeklasa-MuszyńskaJan Dobrogowski. (2017) The role of oxycodone/naloxone in pain management. BÓL 17:4, pages 26-40.
Crossref
Crossref
Stefan Müller-Lissner, Gabrio Bassotti, Benoit Coffin, Asbjørn Mohr Drewes, Harald Breivik, Elon Eisenberg, Anton Emmanuel, Françoise Laroche, Winfried Meissner & Bart Morlion. (2016) Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline. Pain Medicine, pages pnw255.
Crossref
Crossref
MA Ueberall. (2015) Differential Gastrointestinal Effects of Who-Step III Opioids in Low Back Pain Patients with vs. Without Constipation: Post-Hoc Analysis of Data from a 12-Week Prospective, Open-Label Blinded Endpoint Streamlined Study. Global Journal of Anesthesiology, pages 037-051.
Crossref
Crossref
Ignacio Velázquez Rivera, Modesto García Escobar, Jorge Juan Moya Riera, Javier Manuel del Saz de la Torre, Pedro Fenollosa Vázquez, José Manuel González Mesa, Alfonso Casado, Mayte Martín Fuentes & Javier de Andrés Ares. (2015) Changes in Quality of Life after 3 months of Usual Care in a Large Sample of Patients with Noncancer Pain: The “QOOL: Quality of Life and Pain” Study. Pain Practice 15:7, pages 633-642.
Crossref
Crossref
Jan Poelaert, Gineke Koopmans-Klein, Alioune Dioh, Frédéric Louis, Mayken Gorissen, David Logé, Joeri Van Op den bosch & Yvonne J.B. van Megen. (2015) Treatment With Prolonged-Release Oxycodone/Naloxone Improves Pain Relief and Opioid-Induced Constipation Compared With Prolonged-Release Oxycodone in Patients With Chronic Severe Pain and Laxative-Refractory Constipation. Clinical Therapeutics 37:4, pages 784-792.
Crossref
Crossref
Manuel Heim. (2015) Noninterventional Study of Transdermal Fentanyl (Fentavera) Matrix Patches in Chronic Pain Patients: Analgesic and Quality of Life Effects. Pain Research and Treatment 2015, pages 1-9.
Crossref
Crossref
. 2015. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
417
651
.
Bart Morlion, Katri Elina Clemens & Will Dunlop. (2014) Quality of Life and Healthcare Resource in Patients Receiving Opioids for Chronic Pain: A Review of the Place of Oxycodone/Naloxone. Clinical Drug Investigation 35:1, pages 1-11.
Crossref
Crossref
Arturo Cuomo, Gennaro Russo, Gennaro Esposito, Cira Antonietta Forte, Marianna Connola & Claudio Marcassa. (2013) Efficacy and Gastrointestinal Tolerability of Oral Oxycodone/Naloxone Combination for Chronic Pain in Outpatients With Cancer. American Journal of Hospice and Palliative Medicine® 31:8, pages 867-876.
Crossref
Crossref
V. C. P. C. Dongen, P. J. L. Vanelderen, G. Koopmans‐Klein, Y. J. B. Megen, J. Van Zundert & F. J. P. M. Huygen. (2014)
Patient preference with respect to QoL and reduction in opioid‐induced constipation (
OIC
) after treatment with prolonged‐release (
PR
) oxycodone/naloxone compared with previous analgesic therapy [
PREFER
study]
. International Journal of Clinical Practice 68:11, pages 1364-1375.
Crossref
Crossref
Anne Z. DePriest & Katie Miller. (2014) Oxycodone/Naloxone: Role in Chronic Pain Management, Opioid-Induced Constipation, and Abuse Deterrence. Pain and Therapy 3:1, pages 1-15.
Crossref
Crossref
Sabine Hesselbarth, Oliver Löwenstein & Thomas Cegla. (2014) Effects of prolonged-release oxycodone/naloxone on pain control, bowel function and quality of life: A prospective observational study. Scandinavian Journal of Pain 5:2, pages 75-81.
Crossref
Crossref
Celeste B. Burness & Gillian M. Keating. (2014) Oxycodone/Naloxone Prolonged-Release: A Review of Its Use in the Management of Chronic Pain While Counteracting Opioid-Induced Constipation. Drugs 74:3, pages 353-375.
Crossref
Crossref
Antonio Gatti, Manuela Casali, Marzia Lazzari, Giuseppe Tufaro, Paolo Gafforio, Claudia Silvestri, Claudio Marcassa & Alessandro F. Sabato. (2012) Prolonged-Release Oxycodone/Naloxone in Nonmalignant Pain: Single-Center Study in Patients with Constipation. Advances in Therapy 30:1, pages 41-59.
Crossref
Crossref
S. Bader, M. Weber & G. Becker. (2013) Ist die pharmakologische Therapie der Obstipation in der Palliativmedizin evidenzbasiert?Is the pharmacological treatment of constipation in palliative care evidence based?. Der Schmerz 26:5, pages 568-586.
Crossref
Crossref
Christian Compagnone, Fernanda Tagliaferri & Andrea Ramelli. (2011) Some concerns about the article: "High doses of oxycodone–naloxone combination may provide poor analgesia.". Supportive Care in Cancer 20:5, pages 889-890.
Crossref
Crossref
Gálvez Rafael, Provencio Mariano, Sanz-Ortiz Jaime, Ribera Ma Victoria, Esteban Emilio, Collado Francisco, Vara Francisco, Díaz Pilar, Rocafort Javier, Cobo Manuel, Traseira Susana & Brosa Max. (2013) Análisis económico de oxicodona LP/ naloxona LP en el manejo del dolor intenso y el estreñimiento asociado al tratamiento con opioides en España. PharmacoEconomics Spanish Research Articles 9:1, pages 23-34.
Crossref
Crossref
Sam H Ahmedzai, Friedemann Nauck, Gil Bar-Sela, Björn Bosse, Petra Leyendecker & Michael Hopp. (2011) A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain. Palliative Medicine 26:1, pages 50-60.
Crossref
Crossref
John A. Snowden, Sam H. Ahmedzai, John Ashcroft, Shirley D’Sa, Timothy Littlewood, Eric Low, Helen Lucraft, Rhona Maclean, Sylvia Feyler, Guy Pratt & Jennifer M. Bird. (2011) Guidelines for supportive care in multiple myeloma 2011. British Journal of Haematology 154:1, pages 76-103.
Crossref
Crossref
. (2011) Current World Literature. Current Opinion in Supportive & Palliative Care 5:2, pages 174-183.
Crossref
Crossref
Marie-Louise Navez, Florentin Clère, Youlia Kirova, Claire Josse, Bertrand Chuberre & Christian Caussé. (2011) Caractéristiques cliniques des douleurs cancéreuses sévères chez les patients traités par oxycodone. Cohorte OCS2. Douleurs : Evaluation - Diagnostic - Traitement 12:3, pages 110-122.
Crossref
Crossref
. (2010) Current World Literature. Current Opinion in Anaesthesiology 23:5, pages 671-678.
Crossref
Crossref
Peter Holzer. (2010) Opioid antagonists for prevention and treatment of opioid-induced gastrointestinal effects. Current Opinion in Anaesthesiology 23:5, pages 616-622.
Crossref
Crossref